PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
T. occidentalis is suggested as a phytomedicine to manage viral respiratory infections by strengthening immunity [PMID:35260050].
Homeopathic mother tincture and photodynamic therapy (TO-PDT) induced morphological changes indicative of cell death in A549 lung cancer cells [PMID:35910365].
The herb is evaluated for therapeutic potential in managing these complications via antioxidant and anti-inflammatory mechanisms [PMID:39850604].
Evidence summary
PubMed sources
- 1.PMID: 35260050 (2023) — Thuja occidentalis: An Unexplored Phytomedicine with Therapeutic Applications. · Combinatorial chemistry & high throughput screening
- 2.PMID: 11000026 (2000) — Bioactive constituents of Thuja occidentalis. · Journal of natural products
- 3.PMID: 33228192 (2020) — Thuja occidentalis L. (Cupressaceae): Ethnobotany, Phytochemistry and Biological Activity. · Molecules (Basel, Switzerland)
- 4.PMID: 39850604 (2024) — Unlocking the mechanistic potential of Thuja occidentalis for managing diabetic neuropathy and nephropathy. · Journal of traditional and complementary medicine
- 5.PMID: 35910365 (2022) — Photodynamic Effects of Thuja occidentalis on Lung Cancer Cells.